|
December 19, 2005 Categories: New articles Posted by admin
A variety of post-marketing surveillance strategies to monitor the safety of medical devices have been supported by the Food and Drug Administration, but there are few systems to automate surveillance. Authors objective was to develop a system to perform real-time monitoring of safety data using a variety of process control techniques.
First published December 15, 2005 as JAMIA PrePrint
|
|
